• CX-5461 in Cervical Cancer: Mitotic Catastrophe

  2026-08-27

  A 2026 Biochemical Pharmacology study shows that the RNA polymerase I inhibitor CX-5461 suppresses cervical cancer cell growth by coupling DNA damage to abnormal mitotic entry and mitotic catastrophe. The study also reports enhanced cisplatin sensitivity, providing a mechanistic rationale for investigating Pol I inhibition in treatment-resistant cervical cancer models.

• DSS Models and the GPR35–KLF5 Repair Axis

  2026-08-27

  Dextran sulfate sodium salt (MW 35000-45000) is more than a routine colitis reagent: it is a controlled way to interrogate how epithelial injury becomes a repair decision. This thought-leadership guide connects DSS-based intestinal inflammation models with recent evidence on GPR35–KLF5 signaling, then translates that biology into practical study-design and translational strategy.

• Plk1 Control of p31comet in Checkpoint Disassembly

  2026-08-26

  This study identifies Polo-like kinase 1 (Plk1)-dependent phosphorylation of p31comet at S102 as a brake on mitotic checkpoint complex disassembly. The work links a specific post-translational modification to control of the p31comet–TRIP13 pathway, explaining how cells may prevent premature checkpoint silencing during chromosome alignment.

• Purmorphamine: A Cross-Species Smo Assay Map

  2026-08-26

  Purmorphamine is a Smoothened agonist that connects Hedgehog pathway activation with osteogenic and sensory biology. This article translates Apis mellifera findings into a practical framework for interpreting pathway, receptor, and phenotype-level assays.

• Partial BACE Inhibition and Synaptic Transmission

  2026-08-25

  Satir et al. show that partial β-secretase inhibition can reduce amyloid β secretion by up to 50% without measurable loss of synaptic transmission in cultured primary rat neurons. The study defines an experimentally relevant exposure window and suggests that moderate, rather than near-complete, target suppression may be important when designing preventive Alzheimer’s disease interventions.

• Angiotensin Peptides and SARS-CoV-2 Spike Binding

  2026-08-25

  The 2025 reference study shows that naturally occurring angiotensin fragments can increase SARS-CoV-2 spike-protein binding to host receptors, with especially strong effects observed for shorter N-terminal deletion products. Its antibody-based binding strategy provides a framework for examining how renin–angiotensin system peptides may influence viral receptor interactions, while also highlighting the need for cell-based and in vivo validation.

• HRP Goat Anti-Rabbit IgG (H+L) Antibody

  2026-08-24

  This HRP-labeled, affinity-purified polyclonal secondary antibody supports detection of rabbit IgG in Western blot, ELISA, IHC, and ICC workflows. It should be used for research immunoassays with rabbit primary antibodies, not for diagnostic, medical, or automatically validated applications without laboratory-specific optimization.

• Cardamomin Protects Against Oxidative Stroke Damage

  2026-08-24

  The reference study shows that cardamomin from Amomum villosum Lour. protects BV-2 microglia from hydrogen peroxide-induced oxidative injury and reduces damage in a rat permanent middle cerebral artery occlusion model. Its mechanistic contribution is the connection of MEK/ERK-dependent NRF2 activation with suppression of oxeiptosis, AIFM1-associated parthanatos, and ischemic brain injury.

• gamma-Glu-Cys (γ-Glu-Cys): Practical Lab Guide

  2026-08-23

  gamma-Glu-Cys (γ-Glu-Cys), SKU B7887, provides a defined γ-glutamyl-cysteine substrate or intermediate for glutathione synthetase enzyme assay development, glutathione metabolism research, and selected plant or peptide workflows. It is for scientific research only; it should not be used for diagnostic, clinical, or therapeutic applications, and prepared solutions should not be stored long term.

• Moesin and Endothelial Injury in Sepsis

  2026-08-22

  The reference study identifies circulating moesin (MSN) as a biomarker associated with endothelial injury and sepsis severity, while also connecting MSN activity to Rock1/MLC and NF-κB signaling. Its combined patient, animal, and endothelial-cell design provides a practical framework for linking biomarker measurements with vascular permeability mechanisms.

• Reading Plastic Toxicity Through Better Immunodetection

  2026-08-22

  Mechanistic toxicology is only as persuasive as its measurement strategy. This article examines how immunodetection design can strengthen studies of microplastic- and nanoplastic-associated pulmonary fibrosis, while showing where the HRP Rabbit Anti-Goat IgG (H+L) Antibody fits into reproducible translational workflows.

• Azithromycin: Stability-Aware Research Design

  2026-08-21

  Azithromycin is a macrolide antibiotic whose analytical stability can directly influence bacterial infection research. This guide connects ribosomal mechanism, TLC impurity profiling, resistance assays, and cross-domain model selection into a reproducible workflow.

• Ciprofloxacin Hydrochloride: Applied Workflows

  2026-08-20

  Ciprofloxacin hydrochloride is a practical benchmark for bacterial DNA replication inhibition and a useful comparator in host–pathogen screening. This guide translates its fluoroquinolone mechanism, formulation constraints, and emerging immunomodulatory context into reproducible assay workflows and troubleshooting decisions.

• Enzalutamide, ARv7, and TNBC Metastasis

  2026-08-20

  This 2025 study links androgen receptor variant 7 (ARv7) expression with adverse survival and distant metastasis in triple-negative breast cancer (TNBC), then tests AR-directed inhibition in MDA-MB-231 cells. Its main contribution is the integration of patient pathology, TCGA-BRCA analysis, and mechanistic assays to connect AR/ARv7 targeting with EMT and metastasis-related signaling.

• TCAIM Control of OGDH and Mitochondrial Metabolism

  2026-08-19

  The 2025 Molecular Cell study identifies TCAIM as a mitochondrial DNAJC co-chaperone that specifically binds native OGDH and promotes its reduction through HSPA9 and LONP1. This finding expands the role of mitochondrial proteostasis from protein folding toward selective control of metabolic enzyme abundance and carbohydrate catabolism.

8488 records 1/566 page Next 12345 下5页 Last page